Delivery Order SPE2DR25D2209-SPE2DR26FD6LU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,508.05 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors on June 4, 2025, with an ultimate completion date of June 5, 2025. This non-competitive delivery order utilizes a firm fixed-price structure and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.33 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Epinephrine 1 MG/10 ML Luerjet 10ML auto-injectors. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors with a ceiling value of $1,336.96. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Epinephrine 1 mg/10 mL Luerjet 10 mL auto-injectors, with a ceiling value of $3,089.34 and an ultimate completion date of December 4, 2025. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.22 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,303.20 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Epinephrine 1 mg/10 mL Luerjet auto-injectors in 10 mL quantities, with a completion date of August 8, 2025. This contract utilizes firm fixed pricing and represents a non-set-aside, competitively awarded procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,105.47 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 mL Luerjet 10 mL auto-injectors. This non-competitive, firm fixed-price delivery order was awarded on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors with a contract ceiling value of $2,953.92 and an ultimate completion date of June 30, 2025. This competitive award, issued under a firm fixed-price delivery order arrangement with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency has awarded a delivery order valued at $1,797.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date is November 18, 2025, with the award...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,260.01 on December 4, 2025, for the supply of epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed price delivery order with an ultimate completion date of December 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6LUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,333.86 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/10 mL LuerJet auto-injectors on a firm fixed price basis. The award was made on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-competitive delivery order. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to support military healthcare systems worldwide. The company's extensive portfolio of federal contracts reflects its capability to meet diverse pharmaceutical procurement requirements across multiple therapeutic domains, with DLA serving as a primary federal customer for defense-related medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/10/25 |